Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results

K. Vermeersch (Leuven, Belgium), M. Gabrovska (Brussel, Belgium), J. Aumann (Hasselt, Belgium), I. Demedts (Roeselare, Belgium), J. Corhay (Luik, Belgium), E. Marchand (Yvoir, Belgium), H. Slabbynck (Antwerpen, Belgium), C. Haenebalcke (Brugge, Belgium), M. Haerens (Kortrijk, Belgium), S. Hanon (Brussel, Belgium), P. Nguyen (Aalst, Belgium), R. Peché (Charleroi, Belgium), A. Fremault (Charleroi, Belgium), T. Lauwerier (Bonheiden, Belgium), B. Vandenberk (Leuven, Belgium), S. Everaerts (Leuven, Belgium), V. Ninane (Brussel, Belgium), G. Verleden (Leuven, Belgium), T. Troosters (Leuven, Belgium), K. Bogaerts (Leuven, Belgium), G. Brusselle (Gent, Belgium), W. Janssens (Leuven, Belgium)

Source: International Congress 2018 – Clinical trials in COPD: new results
Session: Clinical trials in COPD: new results
Session type: Oral Presentation
Number: 1654
Disease area: Airway diseases

Congress or journal article abstractSlide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Vermeersch (Leuven, Belgium), M. Gabrovska (Brussel, Belgium), J. Aumann (Hasselt, Belgium), I. Demedts (Roeselare, Belgium), J. Corhay (Luik, Belgium), E. Marchand (Yvoir, Belgium), H. Slabbynck (Antwerpen, Belgium), C. Haenebalcke (Brugge, Belgium), M. Haerens (Kortrijk, Belgium), S. Hanon (Brussel, Belgium), P. Nguyen (Aalst, Belgium), R. Peché (Charleroi, Belgium), A. Fremault (Charleroi, Belgium), T. Lauwerier (Bonheiden, Belgium), B. Vandenberk (Leuven, Belgium), S. Everaerts (Leuven, Belgium), V. Ninane (Brussel, Belgium), G. Verleden (Leuven, Belgium), T. Troosters (Leuven, Belgium), K. Bogaerts (Leuven, Belgium), G. Brusselle (Gent, Belgium), W. Janssens (Leuven, Belgium). Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results. 1654

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: